Tibet Aim Pharm. Inc.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Yiming Pharmaceutical) was established in December 2003 and is a comprehensive pharmaceutical enterprise that integrates research and development, production, and sales. The company is headquartered in the National Economic and Technological Development Zone of Lhasa City, Tibet Autonomous Region. Its subsidiaries include Beijing Yiming Kangyuan Pharmaceutical Technology Co., Ltd., Chengdu Yiming Kangyuan Pharmaceutical Technology Co., Ltd., Lhasa Yiming Kangyuan Pharmaceutical Technology Co., Ltd., Beijing Yiming Haizhong Investment Management Co., Ltd., and Sichuan Weiao Pharmaceutical Co., Ltd. The planting base is located in Linzhi, Tibet, and the production base is located in Lhasa and Pengzhou, Sichuan. The marketing network is spread throughout the country. The company has long been committed to the treatment of chronic diseases of the elderly such as diabetes and cardiovascular diseases, and the development and research of core products in the field of gynecology and obstetrics. The company's core products, Yiming Otian Apple Miglitol Tablets, Xintong Gualoupi Injection, Yimei Fen Hydrochloride Namei Fen Injection, Yiming Xinnuoshukabeuterin Injection, Yiming Meixiaodan Hongjin Xiaojie Tablets, Vipifen Acetochlofenac Acid Enteric coated Tablets, have all entered the national medical insurance directory. General medicine products are widely involved in antibiotics, anti allergies, and digestive systems. The company always adheres to the corporate philosophy of "simplicity, pragmatism, innovation, and win-win", being a simple person and doing things pragmatically; Adhering to the business philosophy of R&D driven and result oriented, we now have invention patents, new drug certificates, and drug production registration approvals, including multiple domestic first generic drug patents and award-winning patents. The enterprise has successively obtained honors such as "Tibet Autonomous Region Science and Technology Small and Medium sized Enterprise", "National High tech Enterprise", "National Science and Technology Incubation Enterprise", "Tibet National Science and Technology Incubation Enterprise", "Council Unit of China Cardiovascular Disease Diagnosis and Treatment Industry Technology Innovation Strategy Alliance (Tibet)", "China Patent Excellence Award", etc. In recent years, Yiming Pharmaceutical has benefited from Tibet's unique biological resource advantages and national policy advantages, and the company has developed rapidly. On December 9, 2016, it was officially listed on the Shenzhen Stock Exchange. In the future, the company will continue to leverage its core product advantages, comprehensively analyze and grasp the challenges and opportunities facing the market, adapt to the new national pharmaceutical system reform and development model, and systematically and comprehensively build a high-quality human resource management system, financial management system, and operational development system. Taking the entry into the capital market as a new opportunity, with the corporate vision of "helping patients overcome diseases and always maintaining people's health", and with high-quality and affordable drugs with significant clinical value as the soul, we shoulder the social responsibility that Chinese pharmaceutical companies should have, pursue excellence, and strive to become a leading high-end generic pharmaceutical enterprise in the field of chronic diseases in China. |
| Headquarter | Lhasa City |
| Establish Date | 12/29/2007 |
| Listed Code | 002826.SZ |
| Listed Date | 12/9/2016 |
| Chairman | License. |
| CEO | License. |
| Website | www.emyy.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
